	Efficacy and safety of first-line osimertinib in Chinese patients with EGFR-mutated advanced non-small cell lung cancer: a prospective, multicenter, non-interventional study (FLOURISH). Cancer Biol Med Shen L, Lv D, Tang KJ, Zhao J, Zhu D, Zhao Y, Wang K, Wang Y, Cai Z, Xing L, Xie K, Cui J, Mu L, Cao C, Ding L, Chen P, Liang J, Ding Y, Lu L, Zhang J, Yu X, Chen L, Zheng J, Zhou J, Zhou J. PMID: 42170792 [PubMed - as supplied by publisher]
	Predictive value of systemic inflammatory response index for the occurrence and prognosis of lung metastases in papillary thyroid carcinoma. Am J Transl Res Chen J, Jiang H, Hou X, Zhu Y, Li Z. PMID: 42170428 [PubMed]
	Postoperative pain score and infection risk in lung cancer resection: a propensity score-matching study. Am J Transl Res Liu H, Zhang Y, Xia W, Hu W. PMID: 42170425 [PubMed]
	International Consensus on Severe Lung Cancer-The Second Edition. Transl Lung Cancer Res Lin X, Chu Q, Dong Y, Li M, Lv T, Lin G, Sang L, Tian P, Xia Y, Xie Z, Chen H, Hong C, Jiang J, Jin H, Kuai Z, Liu M, Luo W, Luo Y, Miao Q, Mo W, Pu D, Qiu Y, Qian Z, Sun J, Shi H, Sun Q, Sun Y, Yu Z, Xie X, Xu W, Yi M, Yuan D, Zhang L, Zhao F, Zhong C, Zhan P, Zheng X, Bai C, Chen E, Chen R, Chen X, Cheng Y, Chen Q, Cai L, Cai X, Chen L, Chen Y, Dong W, Deng H, Fang W, Gan X, Hao Y, Hu W, He Y, Hu Y, Hu J, Han B, Hu C, Hu M, Jiang Y, Jin Y, Liu D, Liu W, Li W, Li J, Liu L, Liu J, Li W, Liang W, Lin J, Liu H, Li Z, Li W, Lu N, Lu S, Mu C, Ma H, Miao L, Mu X, Pu X, Peng J, Peng H, Qin J, Qin Y, Ren S, Sun L, Su C, Song Y, Tan X, Tang K, Tang X, Tong J, Wang W, Wu D, Wu L, Wang M, Wang H, Wang Y, Wang H, Wang Q, Wang Z, Wang J, Wang K, Wang F, Xu C, Xie M, Xu A, Xiao K, Xu X, Xu F, Ye X, Yang M, Yang B, Ye X, Ye F, Yu Z, Yue D, Zhang Q, Zou J, Zhang J, Zhuang L, Zhou J, Zhou J, Zhang B, Zhang J, Zhang J, Zhang X, Zhao W, Zhu B, Zhu Z, Zhong W, Zhou C, Zhou Y, He J, Zhong N, Saito Y, Watanabe S, Petrella F, Nakada T, Goto T, Fiorelli A, Solli P, Berardi R, Ichiki Y, Braun M, Nagasaka M, Chouaïd C, Thawani R, Santa-Catalina PG, Styrvoky K, Abbar B, Provencio M, Li S, Chen R, Zhou C. PMID: 42170297 [PubMed]
	Pulmonary ground glass opacity tumor: a curable subtype of lung cancer when treated within the "surgical curative time window". Transl Lung Cancer Res Ye T, Wu H, Chen H. PMID: 42170296 [PubMed]
	Two-year treatment-free sustained remission after chemo-immunotherapy in a 52-year-old male with recurrent ARID1A-mutant lung adenocarcinoma: a case report. Transl Lung Cancer Res Santa-Catalina PG, Morchón-Araujo D, Rodríguez-González M, Sayagués JM, Abad M, Bellido-Hernández L, Fonseca-Sánchez E, Olivares-Hernández A, Del Barco-Morillo E. PMID: 42170293 [PubMed]
	Understanding the dual role of granulocyte-macrophage colony-stimulating factor in the lung cancer tumor microenvironment and its therapeutic implications. Transl Lung Cancer Res Wei G, Zhu X, Zhong R. PMID: 42170292 [PubMed]
	Lung cancer associated with cystic airspaces in the perioperative immunotherapy era: radiologic and pathologic pitfalls, surgical extent, and management implications. Transl Lung Cancer Res He X, Liu Q, Zeng W, Liang Q, Luo J, Chen J, Yu F, Liu W, Chen C. PMID: 42170289 [PubMed]
	Targeted therapy for stage IA non-small cell lung cancer with EGFR mutations: a scoping review. Transl Lung Cancer Res Xie Y, Xia L, Niu Z, Zhang X, Xing Y, Mi X, Dai Z, Zhang G, Hu J, Pu Q. PMID: 42170287 [PubMed]
	Consolidative thoracic radiotherapy after first-line chemoimmunotherapy in extensive-stage small-cell lung cancer: a multicenter retrospective study. Transl Lung Cancer Res Zhang S, Lin N, Gu X, Cheng Z, Lin X, Liang X, Yang X, Chen J, Ma X, Liao H. PMID: 42170285 [PubMed]
	Evaluating the early therapeutic response of radiofrequency ablation in rabbit VX2 lung tumors: a comparison of four diffusion weighted imaging models. Transl Lung Cancer Res Yan Q, Ye W, Shan F, Shi Y, Zhang Z, Cheng Z. PMID: 42170276 [PubMed]
	Prognostic nomogram for extensive-stage small-cell lung cancer in the immunotherapy era: a multicenter study of first-line platinum-etoposide with or without a PD-1/PD-L1 inhibitor. Transl Lung Cancer Res Jing Y, Zhao Y, Zhou Z, Wang J, Wang Y, Ma K, Sun Z, Mu Q, Li W, Ding Y, Zhang H, Jiang Y, Jia X, Tan L, Wang M, Li X. PMID: 42170275 [PubMed]
	Methylated circulating tumor DNA: technical challenges and clinical applications in non-small cell lung cancer patients-a narrative review. Transl Lung Cancer Res Robert M, Sauzay C, Théoleyre S, Vallée A, Fradin D, Pons-Tostivint E, Denis MG. PMID: 42170273 [PubMed]
	Identification of prognostic biomarkers and immunotherapy response predictors in lung adenocarcinoma: integrative Mendelian randomization and machine learning analysis. Transl Lung Cancer Res Cao C, Qin W, Gong R, Luo Z, Zhang H, Yuan X, Zou Y, Fu S, Xiong H. PMID: 42170272 [PubMed]
	Predictors of radiation pneumonitis after postoperative radiotherapy in completely resected pathologic stage III-N2 non-small cell lung cancer: a secondary analysis of a prospective cohort. Transl Lung Cancer Res Wang N, Feng A, Li H, Wang C, Guo J, Yi Y, Zhang Q, Liu J, Yu W, Xu Z, Cai X, Feng W, Fu X. PMID: 42170269 [PubMed]
	The IASLC grading system as a predictor for EGFR-TKI therapy in patients with EGFR-mutant lung adenocarcinoma. Transl Lung Cancer Res Deng C, Zhang M, Fu F, Zheng Q, Li Y, Zhang Y, Chen H. PMID: 42170267 [PubMed]
	Occupational physical workload and risk of lung cancer and chronic respiratory diseases: a prospective cohort study of the UK Biobank. Transl Lung Cancer Res Ma S, Liu Y, Wang Z, Shi X, Yi M, Liu L. PMID: 42170266 [PubMed]
	Mid-term efficacy and safety of transbronchial cryoablation for stage IA peripheral lung cancer: a retrospective analysis. Transl Lung Cancer Res Yang R, Chen J, Xie F, Gu C, Hong S, Zhu H, Jiang Y, Sun J. PMID: 42170263 [PubMed]
	Cadonilimab induction and consolidation for unresectable stage III non-small cell lung cancer patients receiving concurrent chemoradiation: safety run-in results of a prospective, phase II trial. Transl Lung Cancer Res Ni J, Zheng Z, Yang X, Chu X, Zhou Y, Pang Y, Chen H, Yu S, Liang F, Zhu Z, Chu L. PMID: 42170262 [PubMed]
	From biology to the clinic: research evidence and therapeutic advances of TROP2-targeted antibody-drug conjugates in small cell lung cancer. Transl Lung Cancer Res Lu H, Zhu M, Luo Y, Fan Q, Shang L, Wang N, Kong F. PMID: 42170259 [PubMed]

Articles 1 - 20 / 159790

Page 1 of 7990



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy